AI Summary
Thinking
Thinking
We reviewed 41 live results for amjevita adalimumab atto and narrowed them down to the 3 options that look most worth comparing first.
The options are Amjevita (adalimumab-atto), Amgevita (adalimumab-atto) and Idacio (adalimumab).
Source: Amgen Inc.
Description
Amjevita is a prescription biosimilar to Humira (adalimumab) available in the United States. It is used to treat several inflammatory conditions, including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, and plaque psoriasis. This citrate-free medication is delivered via the SureClick autoinjector or single-dose prefilled syringes in various dosages such as 40 mg and 20 mg.
Best for
rheumatoid arthritis patients, US healthcare users, Humira biosimilar seekers and chronic inflammation management
Rate this product
Source: Amgen (Thailand) Limited
Description
Amgevita is a biosimilar to Humira, containing the active substance adalimumab. It is used as a biologic therapy for inflammatory diseases such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, and plaque psoriasis. Available in Thailand as a solution for injection in 20 mg/0.4 ml and 40 mg/0.8 ml pre-filled syringes or autoinjectors, it is classified as a Special Controlled Drug that requires professional medical supervision for prescription and dispensing.
Best for
rheumatoid arthritis patients, biosimilar drug preference, chronic inflammation management and specialized biologic therapy
Rate this product
Source: Fresenius Kabi
Description
Idacio is a biosimilar biologic medication containing adalimumab, a TNF-alpha inhibitor used to treat a wide range of inflammatory conditions. These include rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, and plaque psoriasis. The medication is typically provided as a 40 mg/0.8 mL solution for subcutaneous injection, available in formats such as a single-dose pre-filled pen (autoinjector), a pre-filled syringe, or a single-dose vial for pediatric or specific dosing needs. As a biosimilar, it offers a clinically equivalent and often more accessible alternative to the reference product Humira.
Best for
rheumatoid arthritis treatment, psoriasis management, Crohn’s disease patients, biosimilar medication seekers and subcutaneous injection therapy
Rate this product
| Compare | #1Amjevita (adalimumab-atto) | #2Amgevita (adalimumab-atto) | #3Idacio (adalimumab) |
|---|---|---|---|
| Source | Amgen Inc. | Amgen (Thailand) Limited | Fresenius Kabi |
| Description | Amjevita is a prescription biosimilar to Humira (adalimumab) available in the United States. It is used to treat several inflammatory conditions, including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, and plaque psoriasis. This citrate-free medication is delivered via the SureClick autoinjector or single-dose prefilled syringes in various dosages such as 40 mg and 20 mg. | Amgevita is a biosimilar to Humira, containing the active substance adalimumab. It is used as a biologic therapy for inflammatory diseases such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, and plaque psoriasis. Available in Thailand as a solution for injection in 20 mg/0.4 ml and 40 mg/0.8 ml pre-filled syringes or autoinjectors, it is classified as a Special Controlled Drug that requires professional medical supervision for prescription and dispensing. | Idacio is a biosimilar biologic medication containing adalimumab, a TNF-alpha inhibitor used to treat a wide range of inflammatory conditions. These include rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, and plaque psoriasis. The medication is typically provided as a 40 mg/0.8 mL solution for subcutaneous injection, available in formats such as a single-dose pre-filled pen (autoinjector), a pre-filled syringe, or a single-dose vial for pediatric or specific dosing needs. As a biosimilar, it offers a clinically equivalent and often more accessible alternative to the reference product Humira. |
| Best for | rheumatoid arthritis patients, US healthcare users, Humira biosimilar seekers and chronic inflammation management | rheumatoid arthritis patients, biosimilar drug preference, chronic inflammation management and specialized biologic therapy | rheumatoid arthritis treatment, psoriasis management, Crohn’s disease patients, biosimilar medication seekers and subcutaneous injection therapy |
| Action | Amgen Inc. | Amgen (Thailand) Limited | Fresenius Kabi |
| Rate this product |
"Amjevita (adalimumab-atto) from Amgen Inc.."
TopFind picked this because As the first Humira biosimilar available in the U.S., Amjevita offers a clinically equivalent treatment option supported by Amgen's extensive biopharmaceutical manufacturing expertise.
Note: TopFind AI compiles product and service information for general comparison purposes only.